Fierce Pharma

SEPTEMBER 13, 2024

When Roche's Genentech gained approval for Ocrevus in 2017, the first-in- | The day after Roche gained an FDA approval for its subcutaneous version of cancer drug Tecentriq, the company also scored with a U.S. nod for its under-the-skin formulation of mega-blockbuster multiple sclerosis drug Ocrevus.

FDA 263

FDA Patients 263

MedCity News

APRIL 10, 2023

The share of traditional Medicare enrollees who bought Medicare Supplement coverage rose to 41% in 2021, compared to 35% in 2017, according to a report from America’s Health Insurance Plans. Medicare Supplement enrollees are three times less likely to have issues paying medical bills than those who only have traditional Medicare.

Insurance 274

Insurance Medical 274

Fierce Pharma

MARCH 20, 2024

After Johnson & Johnson last year changed its mind on its 2017 purchase of ap | Idorsia's Tryvio is the first oral anti-hypertensive therapy that uses a new therapeutic mechanism in nearly 40 years, suggesting the dawn of "a new era of endothelin research," the company said.

FDA 258

FDA 258

MedCity News

AUGUST 28, 2022

The biotech company had been collaborating with Takeda Pharmaceutical since 2017. The agreement termination means that two preclinical microbiome therapy candidates for inflammatory bowel disease will now return to Finch Therapeutics.

Pharmaceutical 242

Pharmaceutical Biopharma Pharma 242

MedCity News

DECEMBER 5, 2022

Of this group, 50% provide these benefits through a Medicare Advantage plan, up from 26% in 2017. Currently, only 13% of large employers — or companies with 200 or more employees — offer retiree health benefits, the Kaiser Family Foundation survey found.

246

246

European Pharmaceutical Review

OCTOBER 24, 2022

The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.

Recruitment 91

Recruitment Pharmaceutical Patients Government 91

Fierce Pharma

DECEMBER 6, 2023

In 2017, Daiichi's former subsidiary Plexxikon alleged that Novartis stepped on its Zelboraf patents with its GSK-acquired medicine Tafinlar. After years of back and forth with Daiichi Sankyo over cancer drug patent claims, Novartis has thrown in the towel with a $182 million settlement. |

Medicine 229

Medicine 229

Fierce Pharma

NOVEMBER 7, 2023

Since launching the Regeneron-partnered antibody Dupixent in 2017, Sanofi has relied on the star medicine for sales growth.

Medicine 195

Medicine Sales 195

Fierce Pharma

MAY 31, 2023

After an investigation that dates back to 2017, four former Novartis executives and a Greek politician were cleared of bribery charges. After a yearslong investigation involving politicians and medical professionals alike, Novartis is looking to close the books on its Greek bribery imbroglio.

Doctors 225

Doctors Medical 225

Fierce Pharma

JUNE 20, 2024

The revised deal, first established back in July of 2017, will now see Baxter pay Samsung upwards of $223 million for its manufacturing services through end of 2034. On a revised dealmaking spree this year, Korea’s Samsung Biologics is re-tooling its long-running drug manufacturing pact with Baxter Healthcare. |

Manufacturing 204

Manufacturing Healthcare Healthcare 204

Fierce Pharma

AUGUST 22, 2023

Ingrezza was first approved in tardive dyskinesia in 2017. With a new FDA approval to rival Teva's Austedo, Neurocrine Biosciences’ Ingrezza is debuting in a treatment area with hundreds of millions of dollars of revenue potential. | The FDA approved Ingrezza capsules to treat adult with chorea associated with Huntington’s disease.

FDA 225

FDA Pharmaceutical 225

Fierce Pharma

AUGUST 31, 2023

Bill Sibold, who took over the company's specialty care unit in 2017 just after Dupixent's first approval, is leaving Sanofi effective immediately. For six years, Sanofi's specialty care chief Bill Sibold has helped the company make the most of its Regeneron-partnered immunology superstar Dupixent.

223

223

Fierce Pharma

JULY 27, 2023

scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. About a month and a half after Merck & Co. That didn't take long.

Insurance 179

Insurance 179

Fierce Pharma

JUNE 27, 2023

Equal Employment Opportunity Commission, which sued the company in September over claims it had changed its hiring preferences in 2017 to prioritize recruitment of more millennials to its workforce. . | Eli Lilly will pay out $2.4 million as part of a settlement agreement with the U.S.

Recruitment 198

Recruitment 198

Fierce Pharma

JULY 5, 2023

Since 2017, the company has sold off three PRVs—getting less in return for each successive sale. While the price of just about everything has increased over the last six years in the U.S., the same can’t be said for the cost of an FDA priority review voucher. Just ask Sarepta Therapeutics. | The price of priority review vouchers is falling.

FDA 210

FDA Sales 210

World of DTC Marketing

MARCH 31, 2022

Between 2017 and 2019, pharmacy benefit managers’ gross profit increased by 12 percent despite PBM retention of manufacturer rebates decreasing during this period, according to a report released on Dec. The report showed that the PBM gross profit increased from $25 billion to $28 billion between 2017 and 2019.

Insurance 240

Insurance Prescription Manufacturing Sales 240

World of DTC Marketing

FEBRUARY 17, 2022

In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017.

Medicine 271

Medicine Insurance Leads Medical 271

Fierce Pharma

NOVEMBER 20, 2023

Patients with ultra-rare desmoid tumors now have an FDA-approved treatment, thanks to a drug made by SpringWorks Therapeutics, which spun out of Pfizer in 2017 with a portfolio of rare disease candidates. Thanks to a new FDA approval, patients with ultra-rare desmoid tumors now have an FDA-approved treatment.

FDA 171

FDA Patients 171

Fierce Pharma

JANUARY 24, 2024

Apotex and two of its generics peers have agreed to settle with direct purchasers of their drugs in a price-fixing case that stretches all the way back to 2017. Over the years, myriad generic drugmakers have had to ante up fines and settlement fees for allegedly colluding on the prices of copycat drugs.

154

154

World of DTC Marketing

OCTOBER 21, 2021

The analysis focused on Medicare Part B and Part D spending — which covers outpatient medical care and prescription drugs, respectively, — in 2017, 2018 and 2019, the researchers said.

FDA 234

FDA Insurance Prescription Medicine 234

Fierce Pharma

JUNE 20, 2024

drug authorities met at the FDA's headquarters for the first time since 2017. Takeda has identified a potential challenger to Novartis' Scemblix. Senior officials from China and U.S. And more.

FDA 130

FDA Pharma 130

pharmaphorum

APRIL 8, 2024

Less than half of the cancer therapies given accelerated approval by the FDA in 2013 to 2017 showed a clinical benefit in a confirmatory trial within the next five years

FDA 110

FDA 110

European Pharmaceutical Review

FEBRUARY 17, 2025

Growth and Skills Levy – enabling greater training flexibility Since its introduction in 2017, the Apprenticeship Levy has generated over 21 billion from UK employers, increasing apprenticeship funding from 1.5 billion in 2017/18 to 2.5 billion in 2023/24.

Training 59

Training Pharmaceutical Government Manufacturing 59

Clarivate

APRIL 14, 2022

Our research shows that Ukraine has contributed more than 5,000 scientific publications towards the UN Sustainable Development Goals since 2017, including on peace and justice initiatives (SDG-16). According to our data, Ukraine contributed a total of 5,863 scientific publications towards SDGs since 2017 (see figure 2).

Government 133

Government Education Distribution Food 133

Pharmacy Times

SEPTEMBER 14, 2023

The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.

Medical 55

Medical Patients 55

World of DTC Marketing

MARCH 10, 2022

The increase followed total Humira price hikes of 19 percent during 2017 and 2018. AbbVie, Humira’s manufacturer, kicked off 2020 with a price increase in excess of 7 percent on its mega-blockbuster brand-name treatment.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Marketing 205

European Pharmaceutical Review

NOVEMBER 21, 2022

A study on the surge of new antimicrobial research has shown that despite almost a quarter of a million research papers (227,808) being published on the 12 bacterial families in the World Health Organization (WHO) global priority pathogen list of antibiotic-resistant bacteria from 2017, no new class of antibiotics has gone to market since 1987.

Management 98

Management Leads Pharmaceutical Marketing 98

World of DTC Marketing

FEBRUARY 1, 2022

It dropped more than 15% in 2016 and followed that up with a 44% rise in 2017. The last time the SPDR ETF suffered a drop of 15% or more was in 2018, and the fund followed it up with a 33% increase in 2019. After the Federal Trade Commission formed a working group to scrutinize pharmaceutical mergers, investors are uneasy.

Food and Drug Administration 234

Food and Drug Administration FDA Pharmaceutical Food 234

Pharmaceutical Technology

NOVEMBER 28, 2023

Venture financing for innovative radiopharmaceutical drugs witnessed an approximately 550% increase from $63m in 2017 to $408m in 2023 YTD (year-to-date) total deal value in the US.

98

98

World of DTC Marketing

SEPTEMBER 17, 2020

The adult obesity rate passed 40 percent nationally for the first time according to the 2017–2018 National Health and Nutrition Examination Survey (NHANES), a 26 percent jump from 2007–2008. While there are lots of reasons for this the silence of healthcare providers is a huge reason.

Healthcare 242

Healthcare Healthcare Insurance Healthcare Provider 242

World of DTC Marketing

JUNE 27, 2021

But, will physicians tell patients that results depend on lifestyle intervention and a low-calorie diet? We are an obese country, and diabetes is getting worse.

Side effects 194

Side effects Patients Insurance Doctors 194

Clarivate

APRIL 21, 2022

As can be seen from Figure 1, between 2017-2021, Ukraine’s research output focused on macro topics such as physics (19%), clinical and life sciences (16%), chemistry (16%), social sciences (12%), engineering and material sciences (10%), and electrical engineering (10%) with a total of 52,618 papers published. Source: InCites.

Engineering 98

Engineering Education Electronics Medicine 98

Clarivate

SEPTEMBER 18, 2023

As a pioneer in automated indexing and retrieval of information since 1955, Eugene Garfield (1925-2017) developed citation databases for science that changed how researchers search and assess the scholarly literature.

Specialization 119

Specialization Networking Leads Professional Services 119

World of DTC Marketing

MAY 13, 2021

Manhatten Research Taking The Pulse 2017. 2017 study. Physicians want more from pharma on these websites – for example, 54% of cardiologists want pharma-sponsored continuing medical education on non-pharma websites for providers, and 46% of urologists want disease diagnosis tools. But what about online? Medscape reaches over 3.6

Physicians 173

Physicians Marketing Drug Sample Pharma 173

European Pharmaceutical Review

MARCH 27, 2023

The research includes historic market data from 2017 to 2021, using 2022 as the base year. million in 2017 and continued to grow until 2021. It covers various testing methods such as growth-based, nucleic-acid-based and viability-based. The segment was valued at $1,492.53

Marketing 115

Marketing Pharmaceutical research Pharmaceutical Leads 115

World of DTC Marketing

DECEMBER 2, 2021

A review, authored by researchers at RTI International and the US Food and Drug Administration (FDA), looked at 38 studies published between 1982 and 2017 that examined outcomes reported by patients, prescribers, or both regarding their experience with DTC advertising in the US and New Zealand.

Food and Drug Administration 185

Food and Drug Administration Side effects FDA Prescription 185

World of DTC Marketing

OCTOBER 1, 2020

Porter then moved on to tear apart the $13 million Alles made in 2017 as Celgene’s CEO. ” Porter rhetorically responded, outlining how the average senior in her district couldn’t even afford one pill. She then reminded Alles just how he made “half a million dollars, personally, just by tripling the price of Revlimid.”

Pharma 181

Pharma Patients Competition Sales 181